JOURNAL OF INTERNATIONAL MEDICAL RESEARCH AND HEALTH SCIENCES - Volume 1 Issue 2, (Jul-Sept, 2021)

Pages: 1-6

The truth of diabetes reversal

Sanjay Prakash Dhangar

Category: Nutrition & Dietetics

Download PDF

Abstract:

Diabetes is a real threat to health globally. It neither sees socioeconomic status nor the boundaries. There are now studies that show, at least in short term, that diabetes can be reversed. Various forms of the standard of care are available but suitability differs. Patients would surely choose reversal of their disease if given a choice. The choice can only be given if physicians are not only aware that reversal of diabetes is possible but also need to educate their patients and discuss with them various possibilities and modes of treatment. We here discuss various approaches and studies that prove that diabetes can be reversed and to what extent it is possible to reverse, the real truth about the reversal of diabetes. Apart from these approaches, further research in understanding the mechanism of diabetes reversibility and its overlapping mechanism and pathways that are lacking need to be focussed and emphasized in the future.

Keywords: diabetes, truth, metabolic syndrome, diabetes reversal, diabetes remission

References:

[1] IDF Diabetes Atlas. 9th ed. International Diabetes Federation; Brussels, Belgium, 2019. International Diabetes Federation.

[2] Kannan, Ramya. "India is home to 77 million diabetics, second highest in the world". The Hindu. ISSN 0971-751X.

[3] Geoffrey Migiro. "Countries By Percentage Of World Population". WorldAtlas.

[4] World Health Organization Global Report on Diabetes. Available online: https://www.who.int/diabetes/publications/grd-2016/en/.

[5] Davies M.J., D’Alessio D.A., Fradkin J., Kernan W.N., Mathieu C., Mingrone G., Rossing P., Tsapas A., Wexler D.J., Buse J.B. Management of hyperglycemia in Type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) Diabetes Care. 2018; 41:2669–2701.

[6] Karter A.J., Nundy S., Parker M.M., Moffet H.H., Huang E.S. Incidence of remission in adults with Type 2 diabetes:The Diabetes & Aging Study. Diabetes Care. 2014;37:3188–3195.

[7] Steven S., Carey P.E., Small P.K., Taylor R. Reversal of Type 2 diabetes after bariatric surgery is determined by the degree of achieved weight loss in both short- and long-duration diabetes. Diabet Med. 2015; 32:47–53.

[8] Rubino F., Nathan D., Eckel R.H., Schauer P.R., Alberti K.G., Zimmet P.Z., Del Prato S., Ji L., Sadikot S.M., Herman W.H., et al. Delegates of the 2nd Diabetes Surgery Summit. Metabolic surgery in the treatment algorithm for type 2 diabetes: A joint statement by International Diabetes Organizations. Diabetes Care. 2016; 39:861–877.

[9] Rubino F., Gagner M. Potential of surgery for curing type 2 diabetes mellitus. Ann. Surg. 2002;236:554–559

[10] Cohen R., Caravatto P.P., Correa J.L., Noujaim P., Petry T.Z., Salles J.E., Schiavon C.A. Glycemic control after stomach-sparing duodenal-jejunal bypass surgery in diabetic patients with low body mass index. Surg. Obes. Relat. Dis. 2012; 8:375–380.

[11] Purnell J.Q., Selzer F., Wahed A.S., Pender J., Pories W., Pomp A., Dakin G., Mitchell J., Garcia L., Staten M.A., et al. Type 2 Diabetes Remission Rates After Laparoscopic Gastric Bypass and Gastric Banding: Results of the Longitudinal Assessment of Bariatric Surgery Study. Diabetes Care. 2016; 39:1101–1107

[12] Schauer P.R., Kashyap S.R., Wolski K., Brethauer S.A., Kirwan J.P., Pothier C.E., Thomas S., Abood B., Nissen S.E., Bhatt D.L. Bariatric surgery versus medical therapy in obese patients with diabetes. N. Engl. J. Med. 2012; 366:1567–1576

[13] Kashyap S.R., Bhatt D.L., Wolski K., Watanabe R.M., Abdul-Ghani M., Abood B., Pothier C.E., Brethauer S., Nissen S., Gupta M., et al. Metabolic effects of bariatric surgery in patients with moderate obesity and type 2 diabetes: Analysis of a randomized control trial comparing surgery with intensive medical treatment. Diabetes Care. 2013; 36:2175–2182.

[14] Schauer P.R., Bhatt D.L., Kirwan J.P., Wolski K., Aminian A., Brethauer S.A., Navaneethan S.D., Singh R.P., Pothier C.E., Nissen S.E., et al. Bariatric surgery versus intensive medical therapy for diabetes: 5-year outcomes. N. Engl. J. Med. 2017; 376:641–651.

[15] Eisenbarg D., Azagury D.E., Ghiassi S., Grover B.T., Ki J.J. ASMBS position statement on postprandial hyperinsulinemic hypoglycemia after bariatric surgery. Surg. Obes. Relat. Dis. 2017; 13:371–378.

[16] Pories W.J., Swanson M.S., MacDonald K.G., Long S.B., Morris P.G., Brown B.M., Barakat H.A., de Ramon R.A., Israel G., Dolezal J.M. Who would have thought it? An operation proves to be the most effective therapy for adultonset diabetes mellitus. Ann. Surg. 1995; 222:339–350.

[17] Sjostrom L., Lindroos A.K., Peltonen M., Torgerson J., Bouchard C., Carlsson B., Dahlgren S., Larsson B., Narbro K., Sjostrom D., et al. Lifestyle, diabetes and cardiovascular risk factors 10 years after bariatric surgery. N. Engl. J. Med. 2004; 351:2683–2693.

[18] Bauman W.A., Schwartz E., Rose H.G., Eisenstein H.N., Johnson D.W. Early and long term effects of acute caloric deprivation in obese diabetic patients. Am. J. Med. 1988; 85:38–46.

[19] Hughes T.A., Gwynne J.T., Switzer B.R., Herbst C., White G. Effects of caloric restriction and weight loss on glycemic control, insulin release and resistance, and atherosclerotic risk in obese patients with type II diabetes mellitus. Am. J. Med. 1984; 77:7–17.

[20] Damms-Machado A., Weser G., Bischoff SC. Micronutrient deficiency in obese subjects undergoing low calorie diet. Nutr. J. 2012:11.

[21] Gardner C.D., Kim S., Bersamin A., Dopler-Nelson M., Otten J., Oelrich B., Cherin R. Micronutrient quality of weight-loss diets that focus on macronutrients: Results from the A to Z study. Am. J. Clin. Nutr. 2010; 92:304–312.

[22] Ryan D.H., Espeland M.A., Foster G.D., Haffner S.M., Hubbard V.S., Johnson K.C., Kahn S.E., Knowler W.C., Yanovski S.Z., Look AHEAD Research Group Look AHEAD (Action for Health in Diabetes): Design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes. Control Clin Trials. 2003; 24:610–628.

[23] Gregg E.W., Chen H., Wagenknecht L.E., Clark J.M., Delahanty L.M., Bantle J., Pownall H.J., Johnson K.C., Safford M.M., Kitabchi A.E., et al. Association of an intensive lifestyle intervention with remission of type 2 diabetes. JAMA. 2012;308:2489–2496.

[24] Fothergill E., Guo J., Howard L., Kerns J.C., Knuth N.D., Brychta R., Chen K.Y., Skarulis M.C., Walter M., Walter P.J., et al. Persistent metabolic adaptation 6 years after “The Biggest Loser” competition. Obesity. 2016; 24:1612–1619.

[25] Greenway F.L. Physiological adaptations to weight loss and factors favouring weight regain. Int. J. Obes. 2015; 39:1188–1196.

[26] American Diabetes Association Summary of Revisions: Standards of Medical Care in Diabetes-2019. Diabetes Care. 2019; 42:S4–S6.

[27] Westman E.C., Feinman R.D., Mavropoulos J.C., Vernon M.C., Volek J.S., Wortman J.A., Yancy W.S., Phinney S.D. Low carbohydrate nutrition and metabolism. Am. J. Clin. Nutr. 2007; 86:276–284.

[28] Saslow L.R., Mason A.E., Kim S., Goldman V., Ploutz-Snyder R., Bayandorian H., Daubenmier J., Hecht F.M., Moskowitz J.T. An online intervention comparing a very low-carbohydrate ketogenic diet and lifestyle recommendations versus a plate method diet in overweight individuals with type 2 diabetes: A randomized controlled trial. J. Med. Int. Res. 2017; 19:e36. doi: 10.2196/jmir.5806.

[29] Saslow L.R., Daubenmier J.J., Moskowitz J.T., Kim S., Murphy E.J., Phinney S.D., Ploutz-Snyder R., Goldman V., Cox R.M., Mason A.E., et al. Twelve-month outcomes of a randomized trial of a moderate-carbohydrate versus very low-carbohydrate diet in overweight adults with type 2 diabetes mellitus or prediabetes. Nutr. Diabetes. 2017; 7:304.

[30] Hallberg S.J., McKenzie A.L., Williams P.T., Bhanpuri N.H., Peters A.L., Campbell W.W., Hazbun T.L., Volk B.M., McCarter J.P., Phinney S.D., et al. Effectiveness and safety of a novel care model for the management of type 2 diabetes at 1 year: An open-label, non-randomized, controlled study. Diabetes Ther. 2018; 9:583–612.

[31] Bhanpuri N.H., Hallberg S.J., Williams P.T., McKenzie A.L., Ballard K.D., Campbell W.W., McCarter J.P., Phinney S.D., Volek J.S. Cardiovascular disease risk factor responses to a type 2 diabetes care model including nutritional ketosis induced by sustained carbohydrate restriction at one year: An open label, non-randomized, controlled study. Cardiovasc. Diabetol. 2018; 17:56.

[32] Pramod Tripathi, Maithili Paranjape and Mamata Hiremath. Reversal of Metabolic Syndrome with Freedom From Diabetes (FFD) Protocol: Elixir Endocrinology 122 (2018) 52217-52219.

[33] Pramod Tripathi, Mamata Hiremath, AnaghaVyawahare, AnayDudhbhate. Extent of Diabetic Nephropathy Reversal in Type 2 Diabetes Mellitus Patients by following the Freedom from Diabetes: Indian Journal of Public Health Research & Development, August 2020, Vol. 11(8); 97-105.

[34] Paramesh Shamanna, Suresh Damodharan, BanshiSaboo, Rajeev Chawla, Jahangir Mohammed, Maluk Mohamed & Mohamad Thajudeen. Utilising internet of things and artificial intelligence to enable twin precision treatment for reversal of type 2 Diabetes: Endocrine Abstracts (2020) 70 AEP1027 | DOI: 10.1530/endoabs.70.AEP1027.

[35] Paramesh Shamanna, Banshi Saboo, Suresh Damodharan, Jahangir Mohammed, Maluk Mohamed, Terrence Poon, Nathan Kleinman, and Mohamed Thajudeen. Reducing HbA1c in Type 2 Diabetes Using Digital Twin Technology-Enabled Precision Nutrition: A Retrospective Analysis: Diabetes Ther. 2020 Nov; 11(11): 2703– 2714.

DOI URL: http://doi.org/10.53626/JIMRHS.2021.1201